Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    Study challenges ‘textbook’ view of hematopoiesis

    Author:
    HT Staff
    Publish date: November 9, 2015

    University Health Network Results of a study published in Science challenge traditional ideas about how blood is made. The findings suggest...

    • Read More

    News

    Donor CAR T cells treat aggressive ALL in infant

    Author:
    HT Staff
    Publish date: November 9, 2015

    person treated with UCART19 Photo courtesy of GOSH A hospital in the UK has reported success with the first-in-human use of an allogeneic...

    • Read More

    News

    FDA: Long-term clopidogrel doesn’t affect risk of death

    Author:
    HT Staff
    Publish date: November 7, 2015

    A review conducted by the US Food and Drug Administration (FDA) indicates that long-term use of the antiplatelet drug clopidogrel (Plavix) does...

    • Read More

    News

    RIC can improve HSCT outcomes in older AML patients

    Author:
    HT Staff
    Publish date: November 6, 2015

    Photo by Chad McNeeley Results of a phase 2 study suggest that reduced-intensity conditioning (RIC) may allow older patients with acute myeloid...

    • Read More

    News

    FDA grants drug priority review as FL therapy

    Author:
    HT Staff
    Publish date: November 6, 2015

    The US Food and Drug Administration (FDA) has accepted for priority review a supplemental biologics license application for obinutuzumab (Gazyva)...

    • Read More

    News

    France to lift lifetime ban on MSM blood donors

    Author:
    HT Staff
    Publish date: November 5, 2015

    Photo by Михаило Јовановић France is planning to lift its lifetime ban on blood donations from men who have sex with men (MSM), and the change is...

    • Read More

    News

    EC expands indication for azacitidine in AML

    Author:
    HT Staff
    Publish date: November 5, 2015

    The European Commission (EC) has expanded the approved indication for azacitidine for injection (Vidaza) in acute myeloid leukemia (AML). Now,...

    • Read More

    News

    Experiment reveals new method of RBC production

    Author:
    HT Staff
    Publish date: November 5, 2015

    Photo courtesy of Josh Barney/University of Virginia Health System An unexpected result of a lab experiment has led researchers to a new way to...

    • Read More

    News

    HSC self-renewal depends on surroundings

    Author:
    HT Staff
    Publish date: November 5, 2015

    in the bone marrow Scientists say that, using a model of the hematopoietic system, they have determined which signaling pathways play an...

    • Read More

    News

    Autophagy works in nucleus to ward off cancer

    Author:
    HT Staff
    Publish date: November 4, 2015

    Image by Sarah Pfau Autophagy works in the cell nucleus to guard against the start of cancer, according to research published in Nature. The...

    • Read More

    News

    A new category of cytopenias

    Author:
    HT Staff
    Publish date: November 4, 2015

    New research suggests that clonality may underlie the cytopenias observed in patients with idiopathic cytopenias of undetermined significance (...

    • Read More

    News

    Duo solves mystery regarding FVIII

    Author:
    HT Staff
    Publish date: November 4, 2015

    Turner and Joel Moake Photo from Rice University A pair of researchers solved a long-standing mystery about where factor VIII (FVIII) is made,...

    • Read More

    News

    Drug gets orphan designation for BPDCN

    Author:
    HT Staff
    Publish date: November 3, 2015

    The European Medicines Agency (EMA) has granted orphan drug designation to SL-401 for the treatment of blastic plasmacytoid dendritic cell...

    • Read More

    News

    Protocol could improve massive blood transfusion

    Author:
    HT Staff
    Publish date: November 3, 2015

    An “early and aggressive” approach to massive blood transfusion can save lives in military combat zones and may provide the same benefit in...

    • Read More

    News

    MM-related ESRD on the decline

    Author:
    HT Staff
    Publish date: November 2, 2015

    Photo by Anna Frodesiak New research suggests the risk of end-stage renal disease (ESRD) caused by multiple myeloma (MM) is declining, and...

    • Read More

    Pages

    • « first
    • …
    • 148
    • 149
    • 150
    • 151
    • 152
    • 153
    • 154
    • 155
    • 156
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery